Prediction of risk of metastatic recurrence for female breast cancer patients in the presence of competing causes of death.

Angela B Smith Laura Botta Alice Bernasconi Zhaohui Zou Gemma Gatta Riccardo Capocaccia

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)

These estimates are important in clinical decision making, as higher competing mortality may preclude the benefits of aggressive treatments.

Keyphrases

decision making
squamous cell carcinoma
small cell lung cancer
cardiovascular events
free survival
type diabetes
coronary artery disease